12 insiders reported 148 Form 4 transactions for FENNEC PHARMACEUTICALS INC. (FENC) over the past 18 months (most recent 2026-08-04). Recent activity: Raykov Rosty (Insider) Sell 10,000 shares, Andrade Robert (CHIEF FINANCIAL OFFICER) Buy 1,703 shares, Raykov Rosty (Insider) Buy 2,778 shares, Hackman Jeffrey S. (Chief Executive Officer) Buy 1,159 shares, Evans Terry L (Chief Commercial Officer) Buy 168 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-04 | Raykov Rosty | Insider | Sell | 10,000 | $95,800 |
| 2026-08-03 | Andrade Robert | CHIEF FINANCIAL OFFICER | Buy | 1,703 | $0 |
| 2026-08-03 | Raykov Rosty | Insider | Buy | 2,778 | $0 |
| 2026-08-03 | Hackman Jeffrey S. | Chief Executive Officer | Buy | 1,159 | $0 |
| 2026-08-03 | Evans Terry L | Chief Commercial Officer | Buy | 168 | $0 |
| 2026-08-03 | Sayad Pierre Sargis | Chief Medical Officer | Buy | 168 | $0 |
| 2026-08-03 | Cioffi Christiana Marie | Chief Strategy Officer | Buy | 156 | $0 |
| 2026-07-02 | Raykov Rosty | Insider | Buy | 2,778 | $0 |
| 2026-07-02 | Raykov Rosty | Insider | Buy | 15,597 | $38,213 |
| 2026-07-02 | Raykov Rosty | Insider | Sell | 9,599 | $99,926 |
| 2026-07-01 | Evans Terry L | Chief Commercial Officer | Buy | 168 | $0 |
| 2026-07-01 | Hackman Jeffrey S. | Chief Executive Officer | Buy | 1,159 | $0 |
| 2026-07-01 | Andrade Robert | CHIEF FINANCIAL OFFICER | Buy | 1,703 | $0 |
| 2026-07-01 | Sayad Pierre Sargis | Chief Medical Officer | Buy | 168 | $0 |
| 2026-07-01 | Cioffi Christiana Marie | Chief Strategy Officer | Buy | 156 | $0 |
| 2026-06-02 | Raykov Rosty | Director | Buy | 2,778 | $0 |
| 2026-06-02 | Raykov Rosty | Director | Buy | 15,597 | $38,213 |
| 2026-06-02 | Raykov Rosty | Director | Sell | 9,747 | $93,766 |
| 2026-06-01 | Andrade Robert | CHIEF FINANCIAL OFFICER | Buy | 1,703 | $0 |
| 2026-06-01 | Hackman Jeffrey S. | Chief Executive Officer | Buy | 1,159 | $0 |
| 2026-06-01 | Evans Terry L | Chief Commercial Officer | Buy | 168 | $0 |
| 2026-06-01 | Sayad Pierre Sargis | Chief Medical Officer | Buy | 168 | $0 |
| 2026-06-01 | Cioffi Christiana Marie | Chief Strategy Officer | Buy | 156 | $0 |
| 2026-05-12 | RALLIS CHRIS A | Director | Buy | 14,344 | $34,999 |
| 2026-05-12 | RALLIS CHRIS A | Director | Sell | 8,346 | $58,756 |
Source: SEC Form 4 filings · as of 2026-08-04